
    
      This was a single-center, randomized, open-label, active-controlled, 2-period, 2-sequence,
      single dose-dose, crossover comparison of the ability of Albuterol BOI-HFA to produce
      bronchodilation relative to that produced by to albuterol MDI-HFA in at least 12 asthmatics
      with poor inhaler coordinating ability.
    
  